HOME >> BIOLOGY >> NEWS
Researchers identify genes that may be associated with prognosis in pediatric leukemia

(WASHINGTON, DC, August 25, 2003) A panel of 35 genes have been identified whose expression may be associated with prognosis and response to treatment in pediatric patients with acute myeloid leukemia (AML), according to a study published in the September 1st issue of Blood. At the time of diagnosis, hematologists may be able to use these genes to predict pediatric patient outcomes. Additionally, these genes and their pathways may serve as molecular targets for new therapeutic strategies to prevent relapse of pediatric AML.

AML occurs in both children and adults, although there are some distinct characteristics that distinguish pediatric and adult AML. In children, the primary treatment for AML is chemotherapy, sometimes followed by bone marrow/stem cell transplantation. Most patients with AML enter complete remission after treatment with chemotherapy, but a large number of patients relapse with resistant disease. The prediction of a patient's risk of treatment failure, or even disease relapse, at the time of diagnosis is important for the optimum selection of treatment strategies, such as additional rounds of conventional chemotherapy, stem cell transplantation, or novel experimental therapies.

The 35 genes found were unexpected, and did not correspond to known prognostic genes. Moreover, they were identified independently of currently used classification methods, such as microscopic appearance or specific cytogenetic abnormalities. Additional factors associated with poor prognosis are advanced age, high white blood cell count, extramedullary mass, and a history of blood disorders, such as myelodysplastic syndrome.

Researchers from the Cancer Genomics Division of the National Cancer Center Research Institute in Tokyo, Japan, enrolled 54 pediatric AML patients, all less than 15 years of age. Samples of either bone marrow or peripheral blood were collected and classified at the time of diagnosis. Patients in the study were t
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
25-Aug-2003


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... BALTIMORE, Md. (PRWEB) , ... October 11, 2017 ... ... for digital pathology, announced today it will be hosting a Webinar titled, “Pathology ... of  Advanced Pathology Associates , on digital pathology adoption best practices and how ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/10/2017)... , ... October 10, 2017 , ... San Diego-based team ... its corporate rebranding initiative announced today. The bold new look is part of ... the company moves into a significant growth period. , It will also expand its ...
Breaking Biology Technology:
Cached News: